1-3 of 3
Julie McGrath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II

Glenn J. Hanna, Punita Grover, Andrew Elliott, Julie McGrath, Joanne Xiu, Ammar Sukari, Jennifer M. Johnson, Trisha Wise-Draper
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10): 2225–2232.
https://doi.org/10.1158/1078-0432.CCR-23-3182
Published: 15 May 2024
View article titled, Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II
Open the PDF for Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II in another window
Includes: Supplementary data
Journal Articles

Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

Justin Hwang, Xiaolei Shi, Andrew Elliott, Taylor E. Arnoff, Julie McGrath, Joanne Xiu, Phillip Walker, Hannah E. Bergom, Abderrahman Day, Shihab Ahmed, Sydney Tape, Allison Makovec, Atef Ali, Rami M. Shaker, Eamon Toye, Rachel Passow, John R. Lozada, Jinhua Wang, Emil Lou, Kent W. Mouw, Benedito A. Carneiro, Elisabeth I. Heath, Rana R. McKay, W. Michael Korn, Chadi Nabhan, Charles J. Ryan, Emmanuel S. Antonarakis
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (14): 2702–2713.
https://doi.org/10.1158/1078-0432.CCR-22-3394
Published: 14 July 2023
View article titled, Metastatic Prostate Cancers with <em>BRCA2</em> versus <em>ATM</em> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Open the PDF for Metastatic Prostate Cancers with <em>BRCA2</em> versus <em>ATM</em> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes in another window
Includes: Supplementary data
Journal Articles

Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

Jennifer L. Leddon, Shuchi Gulati, Sulsal Haque, Casey Allen, Sarah Palackdharry, Maria Mathews, Nicky Kurtzweil, Muhammed Kashif Riaz, Vinita Takiar, Misako Nagasaka, Yash Patil, Chad Zender, Alice Tang, Brian Cervenka, Julie McGrath, W. Michael Korn, Benjamin H. Hinrichs, Roman Jandarov, Nusrat Harun, Ammar Sukari, Trisha M. Wise-Draper
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (16): 3464–3472.
https://doi.org/10.1158/1078-0432.CCR-21-4554
Published: 15 August 2022
View article titled, Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
Open the PDF for Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck in another window
Includes: Supplementary data